Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein
- 1 September 1992
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 66 (9), 5635-41
- https://doi.org/10.1128/jvi.66.9.5635-5641.1992
Abstract
Monoclonal antibodies have been isolated from human immunodeficiency virus type 1 (HIV-1)-infected patients that recognize discontinuous epitopes on the gp120 envelope glycoprotein, that block gp120 interaction with the CD4 receptor, and that neutralize a variety of HIV-1 isolates. Using a panel of HIV-1 gp120 mutants, we identified amino acids important for precipitation of the gp120 glycoprotein by three different monoclonal antibodies with these properties. These amino acids are located within seven discontinuous, conserved regions of the gp120 glycoprotein, four of which overlap those regions previously shown to be important for CD4 recognition. The pattern of sensitivity to amino acid change in these seven regions differed for each antibody and also differed from that of the CD4 glycoprotein. These results indicate that the CD4 receptor and this group of broadly neutralizing antibodies recognize distinct but overlapping gp120 determinants.Keywords
This publication has 34 references indexed in Scilit:
- A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activityResearch in Virology, 1991
- A broadly neutralizing monoclonal antibody that recognizes the V3 region of human immunodeficiency virus type 1 glycoprotein gp120.Proceedings of the National Academy of Sciences, 1991
- Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans.Proceedings of the National Academy of Sciences, 1991
- Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp 120AIDS, 1990
- Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160Nature, 1990
- Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.Proceedings of the National Academy of Sciences, 1988
- pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membraneCell, 1987
- Variable and conserved neutralization antigens of human immunodeficiency virusNature, 1986
- Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.Proceedings of the National Academy of Sciences, 1986
- Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.The Journal of Immunology, 1986